Cherry Creek Investment Advisors, Inc. Recursion Pharmaceuticals, Inc. Call Options Transaction History
Cherry Creek Investment Advisors, Inc.
- $178 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RXRX
# of Institutions
258Shares Held
192MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$204 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$199 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$133 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$102 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$86.2 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.49B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...